Home › Companies › HARVARD BIOSCIENCE INC. › 2023-2024

HARVARD BIOSCIENCE INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and HARVARD BIOSCIENCE INC.’s Form 8-K, filed May 14, 2024 (Item 5.07 on EDGAR). Page generated October 25, 2026.

  • 3Ballot items
  • 122Asset managers
  • 514Fund votes
  • May 14, 2024Meeting date

Results at a glance

Meeting of May 14, 2024: 3 items on HARVARD BIOSCIENCE INC.’s Form 8-K, filed May 14, 2024: 2 approved · 1 without a stated outcome.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024

Explore HARVARD BIOSCIENCE INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by HARVARD BIOSCIENCE INC.

These tallies are HARVARD BIOSCIENCE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 14, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

HARVARD BIOSCIENCE INC. — official shareholder meeting results, meeting held May 14, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Alan Edrick 19,722,574---- 10,861,4974,292,458 64%Not verified—
2. Ratification of the Appointment of Grant Thornton LLP 34,794,99573,0038,531 ---- 99.7%Approved—
3. Approval, by Non-Binding Advisory Vote, of the Compensation of the Named Executive Officers 27,472,149903,6082,208,314 --4,292,458 97%Approved—

Source: HARVARD BIOSCIENCE INC., Form 8-K, filed with the SEC on May 14, 2024 — read the filing on EDGAR.

How asset managers voted at the HARVARD BIOSCIENCE INC. 2023-2024 meeting

Each item below shows how the 122 asset managers that disclosed a HARVARD BIOSCIENCE INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Alan Edrick

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

64% Majority: yes · of votes cast

FOR 64%WITHHELD
FOR: 19,722,574WITHHELD: 10,861,497
Details: description as filed, official tally, votes by 48 asset managers

Description as filed by funds: Election of Director: Alan Edrick

HARVARD BIOSCIENCE INC.’s own tally for this item (“Elect Director: Alan Edrick”): 19,722,574 for, 10,861,497 withheld, per its Form 8-K filed May 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 64% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 48 asset managers below reported 5,615,069 for, 4,526,970 withheld, 545,324 abstained, 1,650 unknown.

FORWITHHOLD
FOR: 5,615,069ABSTAIN: 545,324WITHHOLD: 4,526,970UNKNOWN: 1,650
Largest asset managers voting on “Election of Director: Alan Edrick” at HARVARD BIOSCIENCE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,042,3440 00For
Dimensional00 01,648,116Withhold
Royce1,450,8290 00For
BlackRock00 01,350,284Withhold
Fidelity811,9890 0412,870Mixed
HEARTLAND GROUP INC866,4670 00For
Jackson National00 463,6000Abstain
Charles Schwab229,7790 00For
Victory Capital00 0207,389Withhold
BRIDGEWAY FUNDS INC00 0177,500Withhold
FORUM FUNDS II00 0166,857Withhold
TIAA00 0139,999Withhold
Northern Trust00 085,341Withhold
Adirondack Funds82,5780 00For
QUANTITATIVE MASTER SERIES LLC00 074,015Withhold
Equitable00 073,988Withhold
WILSHIRE MUTUAL FUNDS INC00 45,5710Abstain
Goldman Sachs41,2690 00For
Lincoln Financial00 038,369Withhold
Destra Investment Trust00 032,057Withhold
Invesco22,8990 00For
WisdomTree22,2390 00For
John Hancock00 21,6650Abstain
Global X20,9730 00For
AIG/SunAmerica00 020,780Withhold

Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.

2. 3. Approval, by Non-Binding Advisory Vote, of the Compensation of the Named Executive Officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 6 wordings of this item as funds reported it.

97% Approved · of votes cast

FOR 97%
FOR: 27,472,149AGAINST: 903,608
Details: description as filed, official tally, votes by 122 asset managers

Description as filed by funds: APPROVAL, BY A NON-BINDING ADVISORY VOTE, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

HARVARD BIOSCIENCE INC.’s own tally for this item (“3. Approval, by Non-Binding Advisory Vote, of the Compensation of the Named Executive Officers”): 27,472,149 for, 903,608 against — passed, per its Form 8-K filed May 14, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 –Approval, by Non-Binding Advisory Vote, of the Compensation of the Named Executive Officers The Company's stockholders approved the compensation of the Company's named executive officers, by a non-binding advisory vote:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 48 asset managers voting on “APPROVAL, BY A NON-BINDING ADVISORY VOTE, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at HARVARD BIOSCIENCE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,042,3440 00For
Dimensional1,648,1160 00For
Royce1,450,8290 00For
BlackRock1,350,2840 00For
Fidelity1,224,8590 00For
HEARTLAND GROUP INC866,4670 00For
Jackson National463,6000 00For
Charles Schwab229,7790 00For
Victory Capital207,3890 00For
BRIDGEWAY FUNDS INC0177,500 00Against
FORUM FUNDS II166,8570 00For
TIAA139,9990 00For
Northern Trust85,3410 00For
Adirondack Funds82,5780 00For
QUANTITATIVE MASTER SERIES LLC74,0150 00For
Equitable73,9880 00For
WILSHIRE MUTUAL FUNDS INC45,5710 00For
Goldman Sachs41,2690 00For
Lincoln Financial38,3690 00For
Destra Investment Trust32,0570 00For
Invesco22,8990 00For
WisdomTree022,239 00Against
John Hancock21,6650 00For
Global X20,9730 00For
AIG/SunAmerica20,7800 00For

Fund voting reports, all 48 managers: 10,477,561 for, 209,802 against, 1,650 unknown. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 89 asset managers voting on “APPROVAL, BY A NON-BINDING ADVISORY VOTE, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at HARVARD BIOSCIENCE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.2,916,7840 00For
Harvey Partners, LLC2,557,5000 00For
Granahan Investment Management, LLC1,416,1900 00For
BlackRock1,279,661497 00For
HEARTLAND ADVISORS INC866,4670 00For
GEODE CAPITAL MANAGEMENT, LLC855,0850 00For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM682,8490 00For
Portolan Capital Management, LLC682,5350 00For
State Street660,4910 00For
Meros Investment Management, LP556,6590 00For
GREENWOOD CAPITAL ASSOCIATES LLC428,9700 00For
ACADIAN ASSET MANAGEMENT LLC365,6830 00For
Northern Trust359,5210 00For
Renaissance353,5790 00For
KENNEDY CAPITAL MANAGEMENT LLC189,045132,478 00Mixed
Archon Capital Management LLC00 00--
Charles Schwab229,7790 00For
Dimensional211,7190 00For
BRIDGEWAY CAPITAL MANAGEMENT, LLC0184,500 00Against
NEW YORK STATE COMMON RETIREMENT FUND178,3500 00For
MELLON INVESTMENTS Corp0160,339 00Against
Nuveen139,9990 00For
GLOBEFLEX CAPITAL L P136,6020 00For
Connor, Clark & Lunn Investment Management Ltd.122,2670 00For
Newton Investment Management North America, LLC122,2350 00For

Institutional-manager reports, all 89 managers: 16,063,663 for, 601,833 against, 4,700 not voted, 260,858 unknown. Showing the 25 largest; see all in the interactive database.

3. 2. Ratification of the Appointment of Grant Thornton LLP

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.7% Approved · of votes cast

FOR 99.7%
FOR: 34,794,995AGAINST: 73,003
Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: TO RATIFY THE APPOINTMENT OF GRANT THORNTON LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024.

HARVARD BIOSCIENCE INC.’s own tally for this item (“2. Ratification of the Appointment of Grant Thornton LLP”): 34,794,995 for, 73,003 against — passed, per its Form 8-K filed May 14, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 –Ratification of the Appointment of Grant Thornton LLP The Company's stockholders ratified the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 10,604,670 for, 115 against, 1,650 unknown.

FOR
FOR: 10,604,670AGAINST: 115UNKNOWN: 1,650
Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF GRANT THORNTON LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM” at HARVARD BIOSCIENCE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,042,3440 00For
Dimensional1,648,1160 00For
Royce1,450,8290 00For
BlackRock1,350,2840 00For
Fidelity1,224,8590 00For
HEARTLAND GROUP INC866,4670 00For
Jackson National463,6000 00For
Charles Schwab229,7790 00For
Victory Capital207,3890 00For
BRIDGEWAY FUNDS INC177,5000 00For
FORUM FUNDS II166,8570 00For
TIAA139,9990 00For
Northern Trust85,3410 00For
QUANTITATIVE MASTER SERIES LLC74,0150 00For
Equitable73,9880 00For
WILSHIRE MUTUAL FUNDS INC45,5710 00For
Goldman Sachs41,2690 00For
Lincoln Financial38,3690 00For
Destra Investment Trust32,0570 00For
Invesco22,8990 00For
WisdomTree22,2390 00For
John Hancock21,6650 00For
Global X20,9730 00For
AIG/SunAmerica20,7800 00For
Nationwide18,9750 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

Largest HARVARD BIOSCIENCE INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 43,429,626 shares outstanding at the time of that meeting.

Fund voting reports: top HARVARD BIOSCIENCE INC. shareholders by shares voted on “APPROVAL, BY A NON-BINDING ADVISORY VOTE, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE…”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 4.70%
2Dimensional 3.79%
3Royce 3.34%
4BlackRock 3.11%
5Fidelity 2.82%
6HEARTLAND GROUP INC 2.00%
7Jackson National 1.07%
8Charles Schwab 0.53%
9Victory Capital 0.48%
10BRIDGEWAY FUNDS INC 0.41%
Institutional-manager reports: top HARVARD BIOSCIENCE INC. shareholders by shares voted on “APPROVAL, BY A NON-BINDING ADVISORY VOTE, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE…”, 2023-2024
#Asset manager % of shares outstanding
1PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 6.72%
2Harvey Partners, LLC 5.89%
3Granahan Investment Management, LLC 3.26%
4BlackRock 2.95%
5HEARTLAND ADVISORS INC 2.00%
6GEODE CAPITAL MANAGEMENT, LLC 1.97%
7STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 1.57%
8Portolan Capital Management, LLC 1.57%
9State Street 1.52%
10Meros Investment Management, LP 1.28%

Reported HARVARD BIOSCIENCE INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

HARVARD BIOSCIENCE INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
B. Riley Asset Management, LLC 6.77% DEF14A
Punch & Associates Investment Management, Inc. 6.72% DEF14A
Harvey Partners, LLC 5.89% DEF14A
James Green 5.28% DEF14A
Dimensional Fund Advisors 4.44% 13F
Vanguard Group 4.26% 13F
Geode Capital 1.97% 13F
Renaissance Technologies 1.62% 13F
State Street 1.60% 13F
BlackRock 1.43% 13F

Percentages above are of 43,429,626 shares outstanding, as reported by HARVARD BIOSCIENCE INC. on its Form 10-Q dated April 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from HARVARD BIOSCIENCE INC.’s 10-Q dated April 30, 2024. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.

At HARVARD BIOSCIENCE INC.'s shareholder meeting held May 14, 2024, in the 2023-2024 proxy season, 122 asset managers reported how they voted on 3 ballot items in their SEC Form N-PX filings, covering 514 separate fund positions. On the most widely held item on that ballot — APPROVAL, BY A NON-BINDING ADVISORY VOTE, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE… — HARVARD BIOSCIENCE INC.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: HARVARD BIOSCIENCE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 14, 2024.

HARVARD BIOSCIENCE INC. proxy season coverage: 2023-2024 (this page).

Download data (CSV): ballot items · votes by manager · column guide.